Cenupatide
CAS: 1006388-38-0
Ref. TM-TP2338
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire | |
200mg | To inquire |
Product Information
- UPARANT, Cenupatide trifluoroacetic acid salt, Ac-Arg-Aib-Arg-α(Me)Phe-NH2)
Cenupatide is a urokinase plasminogen activator receptor (uPAR) inhibitor. Cenupatide inhibits uPAR binding to the formyl peptide receptors (FPRs) can improve kidney lesions in a rat model of STZ-induced diabetes. Cenupatide reverted STZ-induced up-regulation of uPA levels and activity, while uPAR on podocytes and (s)uPAR were unaffected. In glomeruli, Cenupatide inhibited FPR2 expression.
Chemical properties
Technical inquiry about: TM-TP2338 Cenupatide
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.